Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xbrane Biopharma AB (publ) | 142,261 | net | 15 Mar 2024 | tx 4+142,261 |
| Arcoma aktiebolag | 50,000 | net | 27 May 2020 | tx 1+50,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Mar 2024 | PURCHASE | Xbrane Biopharma AB (publ) | 26,087 | 11.50 SEK | |
| 13 Mar 2024 | PURCHASE | Xbrane Biopharma AB (publ) | 60,087 | 11.50 SEK | |
| 08 Mar 2024 | PURCHASE | Xbrane Biopharma AB (publ) | 26,087 | 0.04 SEK | deriv |
| 29 Feb 2024 | PURCHASE | Xbrane Biopharma AB (publ) | 30,000 | 1.06 SEK | derivfirst after silence |
| 27 May 2020 | PURCHASE | Arcoma aktiebolag | 50,000 | 19.90 SEK |
1 purchase reported after at least 12 months of silence — most recent on 29 Feb 2024.